Navigating the Special Access Scheme (SAS) and Authorised Prescriber Pathways for Medicinal Cannabis Access
At MOCA Health, we are committed to providing Australians with access to high-quality, safe, and effective medicinal cannabis products. The process of obtaining medicinal cannabis can seem complex, but we aim to make it as straightforward and accessible as possible through our telehealth consultations and expert guidance. In Australia, medicinal cannabis is regulated by the Therapeutic Goods Administration (TGA), and there are specific pathways through which patients can gain access to these treatments: the Special Access Scheme (SAS) and the Authorised Prescriber Pathway.
In this article, we’ll explain these two pathways in detail, highlighting how MOCA Health helps guide patients through each process using telehealth consultations, and how we ensure access to the right treatment for your needs.
The Special Access Scheme (SAS) is a pathway established by the TGA that allows medical practitioners to apply for approval to prescribe unapproved therapeutic goods, such as medicinal cannabis, to patients under specific circumstances. This pathway is primarily designed for patients who have medical conditions that may benefit from medicinal cannabis but are unable to access it through conventional means.
The SAS pathway allows for access to medicinal cannabis products that are not yet approved for general sale in Australia. Under this scheme, patients can access cannabis products that have been imported or are not yet registered on the Australian Register of Therapeutic Goods (ARTG). The application process ensures that there is appropriate medical oversight for the use of these products, which are considered "unapproved."
Under the SAS, there are two types of applications:
SAS Category A – This is a more urgent pathway where the patient is experiencing an acute or severe condition, and the treatment is considered necessary for the patient's health.
SAS Category B – This is the standard process, often used for patients with chronic conditions or those for whom other treatments have been ineffective.
MOCA Health facilitates the SAS process by connecting patients with licensed prescribers through telehealth consultations. During the consultation, a licensed medical practitioner will assess your condition, medical history, and determine whether medicinal cannabis is an appropriate treatment option. If so, they will submit an application on your behalf to the TGA for approval under the SAS.
Once approved, the patient can receive a prescription for medicinal cannabis, which can be dispensed by a pharmacy. As part of the process, MOCA Health helps guide patients through the legal and regulatory aspects of medicinal cannabis use, ensuring that all necessary steps are completed for safe and effective treatment.
The Authorized Prescriber Pathway allows a medical practitioner to prescribe medicinal cannabis without needing to apply to the TGA for approval each time. This pathway is typically for medical practitioners who are experienced in prescribing medicinal cannabis and are comfortable using it as part of their practice for treating specific conditions.
A medical practitioner must be an authorized prescriber to prescribe medicinal cannabis to patients under this pathway. To become an authorized prescriber, the practitioner must meet specific criteria and receive approval from the TGA. Once authorized, they can prescribe medicinal cannabis to patients with specific medical conditions that are listed as appropriate for cannabis treatment.
How Does the Authorized Prescriber Pathway Work?
Unlike the SAS, which requires a case-by-case application to the TGA, the Authorized Prescriber Pathway allows an approved doctor to prescribe medicinal cannabis to patients without submitting individual applications. This makes the process faster and more streamlined for patients who need regular access to medicinal cannabis for ongoing treatment.
The authorized prescriber pathway is often used for patients with chronic conditions such as chronic pain, anxiety, insomnia, and epilepsy, or for those undergoing cancer treatment. By using this pathway, patients can avoid the delays associated with the SAS and benefit from more continuous and accessible treatment options.
At MOCA Health, we connect patients with authorized prescribers who are experienced in the use of medicinal cannabis. Our telehealth consultations make it easy to access the right medical advice from the comfort of your home, and our team works closely with authorized prescribers to ensure that patients receive the right cannabis products and dosages for their conditions.
In both the SAS and Authorized Prescriber Pathways, telehealth consultations play a pivotal role in ensuring that patients can access treatment without the need for in-person visits. This is particularly important for patients who live in rural or remote areas where access to specialized care may be limited.
At MOCA Health, our telehealth consultations make it easier for patients to receive assessments, prescriptions, and ongoing care from the convenience of their home or office. Whether you are seeking access to medicinal cannabis through the SAS or through an authorized prescriber, MOCA Health’s telehealth consultations provide a seamless and secure way to connect with medical professionals.
Benefits of Telehealth Consultations for Medicinal Cannabis Access:
Convenience: You can book an appointment at a time that suits you, without the need to travel long distances.
Access to Expert Care: You can consult with licensed prescribers who have experience with medicinal cannabis, no matter where you are in Australia.
Personalized Treatment: During the consultation, our medical practitioners will assess your medical condition and work with you to develop a personalized treatment plan.
Ongoing Support: You will receive follow-up consultations to monitor your progress and adjust your treatment plan if needed.
Booking a telehealth consultation with MOCA Health is simple and user-friendly. The process involves the following steps:
Book an Appointment: Visit our website to schedule a telehealth consultation at a time that works best for you.
Consultation: During the appointment, a licensed medical professional will assess your condition, discuss your medical history, and determine if medicinal cannabis is an appropriate treatment option.
Prescribing Medicinal Cannabis: If medicinal cannabis is deemed suitable, the medical professional will guide you through the application process for the SAS or provide you with access through the Authorized Prescriber Pathway.
Follow-Up Care: After the consultation, you will receive guidance on how to use your prescribed medicinal cannabis and any necessary follow-up care, which can be conducted through additional telehealth appointments.
At MOCA Health, our mission is to make access to medicinal cannabis as easy and transparent as possible. We offer clear guidance on the SAS and Authorized Prescriber Pathways, and our team is dedicated to supporting you at every stage of the process. Whether you are a first-time user or have experience with medicinal cannabis, we ensure you are fully informed and confident in your treatment plan.
Navigating the Special Access Scheme (SAS) and the Authorized Prescriber Pathway for medicinal cannabis access in Australia can be overwhelming. However, with the right support and guidance, patients can successfully access the treatment they need. MOCA Health is here to provide the support you need through telehealth consultations, ensuring that you receive personalized, high-quality care, no matter where you are located in Australia.
If you are considering medicinal cannabis as part of your treatment plan, MOCA Health is ready to help. Book your telehealth consultation today, and take the first step toward finding the right treatment for your health needs.